ABCC transporter inhibition reduces zymosan-induced peritonitis

Journal of Leukocyte Biology

Volumn 82, Issue 3, 2007, Pages 630-637

  Leite, Daniela F P ^a,b   Echevarria Lima, Juliana ^a   Ferreira, Samira Cardoso ^b   Calixto, João B ^b   Rumjanek, Vivian M ^a,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c Instituto de Bioquímica Médica   (Brazil)

Author keywords

IL 1 ; LTC4; Macrophages; MK571; NOx; PGE2; Probenecid; ROS; TNF

Indexed keywords

ABC TRANSPORTER; BINDING PROTEIN; INTERLEUKIN 1BETA; LEUKOTRIENE C4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MK571; PROBENECID; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL COUNT; CELL MIGRATION; CELL SECRETION; CELL STRUCTURE; CONTROLLED STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PAW EDEMA; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

EID: 34548460803     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0107042     Document Type: Article

References (35)

1. Doherty, N. X., Poubelle, P., Borgeat, P., Beaver, T. H., Westrich, G. L., Schrader, N. L. (1985). Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2. Prostaglandins 30, 769-789.
2. Lawrence, T., Willoughby, D. A., Gilroy, D. W. (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2, 787-795.
3. Nathan, C. (2002) Points of control in inflammation. Nature 420, 846-852.
4. Sherwood, E. R., Toliver-Kinsky, T. (2004) Mechanisms of the inflammatory response. Best Pract. Res. Clin. Anaesthesiol. 18, 385-405.
5. Kolaczkowska, E., Seljelid, R., Plytycz, B. (2001) Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J. Leukoc. Biol. 69, 33-42.
6. Kolaczkowska, E., Shahzidi, S., Seljelid, R., van Rooijen, N., Plytycz, B. (2002) Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 26, 61-71.
7. Yopp, A. C., Randolph, G. J., Bromberg, J. S. (2003) Leukotrienes, sphingolipids, and leukocyte trafficking. J. Immunol. 171, 5-10.
8. Chen, Z. S., Guo, Y., Belinsky, M. G., Kotova, E., Kruh, G. D. (2005) Transport of bile acids, sulfated steroids, estradiol 17-β-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol. Pharmacol. 67, 545-557.
9. De Waart, D. R., Paulusma, C. C., Kunne, C., Oude Elferink, R. P. (2006) Multidrug resistance associated protein 2 mediates transport of prostaglandin E2. Liver Int. 26, 362-368.
10. Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., Keppler, D. (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269, 27807-27810.
11. Zeng, H., Liu, G., Rea, P. A., Kruh, G. D. (2000) Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res. 60, 4779-4784.
12. Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A., Zaman, G. J., Mayer, U., Beijnen, J. H., van der Valk, M., Krimpenfort, P., Borst, P. (1997) Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3, 1275-1279.
13. Schultz, M. J., Wijnholds, J., Peppelenbosch, M. P., Vervoordeldonk, M. J., Speelman, P., van Deventer, S. J., Borst, P., van der Poll, T. (2001) Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia. J. Immunol. 166, 4059-4064.
14. Echevarria-Lima, J., Kyle-Cezar, F., Leite, D. F. P., Capella, L., Capella, M. A., Rumjanek, V. M. (2005) Expression and activity of multidrug resistance protein 1 in a murine thymoma cell line. Immunology 114, 468-475.
15. Leite, D. F., Echevarria-Lima, J., Salgado, L. T., Capella, M. A., Calixto, J. B., Rumjanek, V. M. (2006) In vivo and in vitro modulation of MDR molecules in murine thymocytes. Int. Immunopharmacol. 6, 204-215.
16. Granger, D. L., Hibbs Jr., J. B., Perfect, J. R., Durack, D. T. (1990) Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest. 85, 264-273.
17. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., Tannenbaum, S. R. (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138.
18. Barth, M. W., Hendrzak, J. A., Melnicoff, M. J., Morahan, P. S. (1995) Review of the macrophage disappearance reaction. J. Leukoc. Biol. 57, 361-367.
19. Issekutz, A. C., Issekutz, T. B. (1993) Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 α, tumor necrosis factor-α, and IFN-γ. J. Immunol. 151, 2105-2115.
20. Bakos, E., Evers, R., Sinko, E., Varadi, A., Borst, P., Sarkadi, B. (2000) Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol. 57, 760-768.
21. Zelcer, N., Saeki, T., Reid, G., Beijnen, J. H., Borst, P. (2001) Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J. Biol. Chem. 276, 46400-46407.
22. Gekeler, V., Ise, W., Sanders, K. H., Ulrich, W. R., Beck, J. (1995) The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208, 345-352.
23. Reid, G., Wielinga, P., Zelcer, N., De Haas, M., Van Deemter, L., Wijnholds, J., Balzarini, J., Borst, P. (2003) Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol. Pharmacol. 63, 1094-1103.
24. De Bittencourt Junior, P. I., Senna, S. M., Vidor, A. C., Miyasaka, C. K., Curi, R., Williams, J. F. (1998) Glutathione metabolism and glutathione S-conjugate export ATPase (MRP1/GS-X pump) activity in cancer. II. Cell-to-cell variability, relation with cellular activation state and functional absence of GS-X pump in lymphocytes. Biochem. Mol. Biol. Int. 45, 1243-1254.
25. Leite, D. F., Echevarria-Lima, J., Calixto, J. B., Rumjanek, V. M. (2007) Multidrug resistance related protein (ABCC1) and its role on nitrite production by the murine macrophage cell line RAW 264.7. Biochem. Pharmacol. 73, 665-674.
26. Leslie, E. M., Deeley, R. G., Cole, S. P. (2001) Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 167, 3-23.
27. Kolaczkowska, E. (2002) Shedding light on vascular permeability during peritonitis: role of mast cell histamine versus macrophage cysteinyl leukotrienes. Inflamm. Res. 51, 519-521.
28. Reid, G., Wielinga, P., Zelcer, N., van der Heijden, I., Kuil, A., de Haas, M., Wijnholds, J., Borst, P. (2003) The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. USA 100, 9244-9249.
29. Byrum, R. S., Goulet, J. L., Snouwaert, J. N., Griffiths, R. J., Koller, B. H. (1999) Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J. Immunol. 163, 6810-6819.
30. Rao, T. S., Currie, J. L., Shaffer, A. F., Isakson, P. C. (1994) In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther. 269, 917-925.
31. Pawlik, A., Baskiewicz-Masiuk, M., Machalinski, B., Safranow, K., Gawronska-Szklarz, B. (2005) Involvement of P-glycoprotein in the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. J. Pharm. Pharmacol. 57, 1421-1425.
32. Hamon, Y., Luciani, M. F., Becq, F., Verrier, B., Rubartelli, A., Chimini, G. (1997) Interleukin-1β secretion is impaired by inhibitors of the ATP binding cassette transporter, ABC1. Blood 90, 2911-2915.
33. Yao, V., McCauley, R., Cooper, D., Platell, C., Hall, J. C. (2004) Zymosan induces nitric oxide production by peritoneal mesothelial cells. ANZ J. Surg. 74, 266-269.
34. Hui, Y., Cheng, Y., Smalera, I., Jian, W., Goldhahn, L., Fitzgerald, G. A., Funk, C. D. (2004) Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation 110, 3360-3366.
35. Verbon, A., Leemans, J. C., Weijer, S., Florquin, S., Van Der Poll, T. (2002) Mice lacking the multidrug resistance protein 1 have a transiently impaired immune response during tuberculosis. Clin. Exp. Immunol. 130, 32-36.